[Urgent] Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.

Click here now for the urgent details on this hidden play.

Gerard Brophy Biography and Net Worth

EVP of Avantor

Dr. Ger Brophy is our Executive Vice President, Biopharma Production. In his current role, Dr. Brophy is responsible for developing and implementing our Biopharma Production offering to support the current and future needs of our customers. Prior to joining Avantor, Dr. Brophy held a variety of research and development, strategy, advanced systems, and business development positions with GE Healthcare Life Sciences, GE Healthcare Medical Diagnostics and Amersham for nearly 30 years. Dr. Brophy earned a Bachelor of Science in biotechnology, as well as a doctorate in molecular biology from Dublin City University in Ireland.

What is Gerard Brophy's net worth?: The estimated net worth of Gerard Brophy is at least $2.25 million as of March 3rd, 2023. Dr. Brophy owns 108,715 shares of Avantor stock worth more than $2,247,139 as of November 22nd. This net worth estimate does not reflect any other investments that Dr. Brophy may own. Learn More about Gerard Brophy's net worth.
How do I contact Gerard Brophy?: The corporate mailing address for Dr. Brophy and other Avantor executives is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. Avantor can also be reached via phone at (610) 386-1700 and via email at [email protected]. Learn More on Gerard Brophy's contact information.
Has Gerard Brophy been buying or selling shares of Avantor?: Gerard Brophy has not been actively trading shares of Avantor within the last three months. Most recently, Gerard Brophy sold 3,914 shares of the business's stock in a transaction on Friday, March 3rd. The shares were sold at an average price of $25.00, for a transaction totalling $97,850.00. Following the completion of the sale, the executive vice president now directly owns 108,715 shares of the company's stock, valued at $2,717,875. Learn More on Gerard Brophy's trading history.
Who are Avantor's active insiders?: Avantor's insider roster includes James Bramwell (EVP), Gerard Brophy (EVP), Christophe Couturier (EVP), Steven Eck (CAO), Rajiv Gupta (Director), Justin Miller (EVP), Jo Natauri (Director), Devashish Ohri (EVP), Christi Shaw (Director), Michael Stubblefield (CEO), Thomas Szlosek (CFO), Frederic Vanderhaegen (EVP), and Michael Wondrasch (EVP). Learn More on Avantor's active insiders.
Are insiders buying or selling shares of Avantor?: In the last twelve months, insiders at the sold shares 2 times. They sold a total of 9,728 shares worth more than $240,247.97. The most recent insider tranaction occured on September, 5th when CAO Steven W Eck sold 3,525 shares worth more than $88,336.50. Insiders at Avantor own 1.5% of the company. Learn More about insider trades at Avantor.
Information on this page was last updated on 9/5/2024.

Gerard Brophy Insider Trading History at Avantor

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/3/2023	Sell	3,914	$25.00	$97,850.00	108,715
2/2/2023	Sell	11,339	$25.06	$284,155.34	102,385
5/20/2022	Sell	19,603	$31.27	$612,985.81	96,935
3/1/2022	Sell	2,027	$34.47	$69,870.69
2/23/2022	Sell	3,059	$33.79	$103,363.61
1/5/2022	Sell	11,551	$38.65	$446,446.15
1/3/2022	Sell	59,418	$40.77	$2,422,471.86
7/30/2021	Sell	81,125	$37.24	$3,021,095.00
2/24/2021	Sell	3,059	$27.93	$85,437.87	172,384
2/22/2021	Sell	19,769	$28.62	$565,788.78	175,443
1/6/2021	Sell	11,509	$27.24	$313,505.16	178,515
1/4/2021	Sell	59,418	$27.84	$1,654,197.12	190,024
5/20/2020	Sell	25,495	$17.36	$442,593.20	196,583

Gerard Brophy Buying and Selling Activity at Avantor

Avantor Company Overview

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Today's Range

Now: $20.67

$20.25

$20.71

50 Day Range

MA: $24.01

$19.72

$27.70

2 Week Range

Now: $20.67

$19.59

$28.00

Volume

2,416,084 shs

Average Volume

6,479,590 shs

Market Capitalization

$14.07 billion

P/E Ratio

44.93

Dividend Yield

N/A

Beta

1.35